These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16880933)

  • 1. Establishment of the platform for reverse chemical genetics targeting novel protein-protein interactions.
    Koga H
    Mol Biosyst; 2006 Mar; 2(3-4):159-64. PubMed ID: 16880933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
    Watt PM
    Nat Biotechnol; 2006 Feb; 24(2):177-83. PubMed ID: 16465163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets.
    Vogt A; Lazo JS
    Pharmacol Ther; 2005 Aug; 107(2):212-21. PubMed ID: 15925410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. InCeP: intracellular pathway based on mKIAA protein-protein interactions.
    Murakami M; Shimada K; Kawai M; Koga H
    DNA Res; 2005; 12(5):379-87. PubMed ID: 16769695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From systematic analysis of protein interaction networks to chemical-biology].
    Natsume T
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1649-54. PubMed ID: 18051394
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of mass spectrometry technologies for the discovery of low-molecular weight modulators of enzymes and protein-protein interactions.
    Zehender H; Mayr LM
    Curr Opin Chem Biol; 2007 Oct; 11(5):511-7. PubMed ID: 17931957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural product-like synthetic libraries.
    Thomas GL; Johannes CW
    Curr Opin Chem Biol; 2011 Aug; 15(4):516-22. PubMed ID: 21684804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational drug design via intrinsically disordered protein.
    Cheng Y; LeGall T; Oldfield CJ; Mueller JP; Van YY; Romero P; Cortese MS; Uversky VN; Dunker AK
    Trends Biotechnol; 2006 Oct; 24(10):435-42. PubMed ID: 16876893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of antibacterial agents using diversity-oriented synthesis.
    Galloway WR; Bender A; Welch M; Spring DR
    Chem Commun (Camb); 2009 May; (18):2446-62. PubMed ID: 19532856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Databases of protein-protein interactions and their use in drug discovery.
    Fuentes G; Oyarzabal J; Rojas AM
    Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an "undruggable" class of disease targets.
    Visintin M; Melchionna T; Cannistraci I; Cattaneo A
    J Biotechnol; 2008 May; 135(1):1-15. PubMed ID: 18395925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for ligands using a generic and high-throughput light-scattering-based assay.
    Senisterra GA; Markin E; Yamazaki K; Hui R; Vedadi M; Awrey DE
    J Biomol Screen; 2006 Dec; 11(8):940-8. PubMed ID: 17092916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity capillary electrophoresis analyses of protein-protein interactions in target-directed drug discovery.
    Pierceall WE; Zhang L; Hughes DE
    Methods Mol Biol; 2004; 261():187-98. PubMed ID: 15064459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How good is your screening library?
    Irwin JJ
    Curr Opin Chem Biol; 2006 Aug; 10(4):352-6. PubMed ID: 16797220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products as a screening resource.
    Harvey AL
    Curr Opin Chem Biol; 2007 Oct; 11(5):480-4. PubMed ID: 17884696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scalable approach to combinatorial library design for drug discovery.
    Sharma P; Salapaka S; Beck C
    J Chem Inf Model; 2008 Jan; 48(1):27-41. PubMed ID: 18052333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computationally guided protein-interaction screen uncovers coiled-coil interactions involved in vesicular trafficking.
    Zhang H; Chen J; Wang Y; Peng L; Dong X; Lu Y; Keating AE; Jiang T
    J Mol Biol; 2009 Sep; 392(1):228-41. PubMed ID: 19591838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and implementation of cell-based assays to model human disease.
    Jones JO; Diamond MI
    ACS Chem Biol; 2007 Nov; 2(11):718-24. PubMed ID: 18030988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.